Heart Failure
📧 Sign up to get email alerts when something new happens for Heart Failure.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2006-10-13Clinical Trial Update: Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks [Phase 2, Phase 3]
An update on the Phase 2 and Phase 3 trial Anticipatory & Preventive Team Care (APTCare) for at-risk patients within Family Health Networks,…
-
CLINICAL_TRIALS trial_result · 2006-10-11Clinical Trial Update: Effects of Exercise Training on Diastolic Heart Function in Postmenopausal Women [NA]
A completed NHLBI clinical trial evaluated the effects of exercise training on diastolic heart function in postmenopausal women.
-
CLINICAL_TRIALS research · 2006-10-11Clinical Trial Update: Iron Supplementation in Heart Failure Patients With Anemia: The IRON-HF Study [Phase 2, Phase 3]
Clinical trial update on iron supplementation for heart failure patients with anemia, spanning Phase 2 and Phase 3 stages.
-
CLINICAL_TRIALS research · 2006-10-04Clinical Trial Update: BNP Testing in Patients With SOB on Presentation to ED [Phase 1]
Phase 1 clinical trial update evaluating BNP testing in patients presenting with shortness of breath to the emergency department, focusing o…
-
CLINICAL_TRIALS trial_result · 2006-09-27Clinical Trial Update: Effects of Carvedilol on Health Outcomes in Heart Failure [Phase 4]
Phase 4 clinical trial evaluating carvedilol's effects on health outcomes in congestive heart failure has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2006-09-18FDA Approved: FUROSEMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the Original Application for furosemide from Ipca Laboratories Limited, enabling a generic version of the diuretic to be market…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Evaluation of a Primary Care Based Heart Failure Management Program [Phase 2, Phase 3]
A clinical trial entry describing a primary care-based heart failure management program evaluated in Phase 2 and Phase 3, sponsored by Hamil…
-
FDA approval · 2006-08-28FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Coreg (carvedilol) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Acupuncture in Cardiovascular Disease [Phase 2]
Phase 2 clinical trial evaluating acupuncture for heart failure has completed.
-
FDA approval · 2006-08-17FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for ATACAND (candesartan cilexetil) submitted by ANI Pharmaceuticals, Inc., to modify or expand the …
-
FDA approval · 2006-08-08FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2006-07-27FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…
-
CLINICAL_TRIALS trial_result · 2006-07-04Clinical Trial Update: ACCLAIM - Advanced Chronic Heart Failure CLinical Assessment of Immune Modulation Therapy [Phase 3]
Phase 3 trial ACCLAIM evaluated immune modulation therapy for advanced chronic heart failure; the study has completed.
-
FDA approval · 2006-07-03FDA Approved: LISINOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' supplemental application for lisinopril, authorizing the continued marketing of its lisinopril gene…
-
CLINICAL_TRIALS trial_result · 2006-06-27Clinical Trial Update: Effects of Acute L-NMMA Treatment on Renal Hemodynamics and Vasoactive Hormones in Patients With Congestive Heart Failure [Phase 1]
Phase 1 study assessing how acute L-NMMA affects renal hemodynamics and vasoactive hormones in patients with heart failure has been complete…
-
CLINICAL_TRIALS trial_result · 2006-06-23Clinical Trial Update: Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) Trial [Phase 3]
A Phase 3 randomized, blinded trial evaluating hawthorn extract for chronic heart failure has completed.
-
FDA approval · 2006-06-20FDA Approved: QUINAPRIL — Original Application (BluePoint Laboratories)
FDA approved the original ANDA for Quinapril from BluePoint Laboratories, establishing a generic version of the ACE inhibitor used to treat …
-
FDA approval · 2006-06-08FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))
The FDA issued approval for a supplemental application for lisinopril from Heritage Pharmaceuticals (Avet), authorizing marketing of a gener…
-
CLINICAL_TRIALS research · 2006-05-26Clinical Trial Update: Registry and Survey of Women With Pregnancy Related Cardiomyopathy
This entry describes a registry and survey study of women with pregnancy-associated cardiomyopathy, sponsored by St. Vincent's Medical Cente…
-
CLINICAL_TRIALS trial_result · 2006-05-15Clinical Trial Update: Multidisciplinary Inpatient Palliative Care Intervention [NA]
A completed clinical trial evaluating a multidisciplinary inpatient palliative care intervention; the snippet notes status (COMPLETED) and p…
-
FDA approval · 2006-05-04FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.